AD AWARD NUMBER DAMD17-96-1-6079 TITLE: Breast Cancer Genes Identified by Loss of Heterozygosity PRINCIPAL INVESTIGATOR:

AD AWARD NUMBER DAMD17-97-1-7144 TITLE: Tomosynthesis Breast Imaging: Early Detection and Characterization of Breast Cancer PRINCIPAL INVESTIGATOR:

AWARD NUMBER DAMD17-97-1-7144 TITLE: Tomosynthesis Breast Imaging: Early Detection and Characterization of Breast Cancer PRINCIPAL INVESTIGATOR: Loren T. Niklason, Ph.D. CONTRACTING ORGANIZATION: Massachusetts General Hospital Boston, Massachusetts 02114 REPORT DATE: July 1998 ^\$> TYPE OF REPORT: Annual "P^ PREPARED FOR: Commander U.S. Army Medical Research and Materiel Command Fort Detrick, M...

AD GRANT NUMBER DAMD17-96-1-6194 TITLE: The Effect of Radiotherapy Upon Primary Human Mammary Epithelial Cells Which Harbor a Breast Cancer Susceptibility Gene PRINCIPAL INVESTIGATOR:

AWARD NUMBER: DAMD17-02-1-0350 TITLE: “Identification of the Downstream Promoter Targets of Smad Tumor Suppressors in Human Breast Cancer Cells” PRINCIPAL INVESTIGATOR:

AWARD NUMBER: DAMD17-02-1-0503 TITLE: ATM Mutations and the Development of Severe Radiation-Induced Morbidity Following Radiotherapy for Breast Cancer PRINCIPAL INVESTIGATOR:

AD AWARD NUMBER DAMD17-97-1-7140 TITLE: Prognostic Significance of Loss-of-Heterozygosity of the CUTL1 Putative Tumor Suppressor Gene in Breast Cancers